Flixotide Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Fluticasone propionate

Indications/Uses

Reduces symptoms & exacerbations of asthma in patients previously treated w/ bronchodilator alone or w/ other prophylactic therapy. Prophylactic management of mild, moderate & severe asthma in adults & childn. COPD in combination w/ long-acting bronchodilators.

Click to view Flixotide detailed prescribing information

Dosage/Direction for Use

Adult & childn >16 yr Mild asthma 100-250 mcg bid. Moderate asthma 250-500 mcg bid. Severe asthma 500-1,000 mcg bid. Childn ≥4 yr 50-200 mcg bid. Patients whose asthma is sufficiently controlled May increased dose up to 200 mcg bid. Adult COPD 500 mcg bid as adjunct to long-acting bronchodilators.

Click to view Flixotide detailed prescribing information

Overdosage

View Flixotide overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Flixotide detailed prescribing information

Special Precautions

Development of pneumonia in patients w/ COPD. Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in childn & adolescents, decrease in bone mineral density, cataract, glaucoma & central serous chorioretinopathy. Possibility of impaired adrenal response in patients transferring from oral to inhaled therapy. Possible need for additional therapy in times of stress. May unmask allergies eg, allergic rhinitis or eczema. Do not stop treatment abruptly. Patients w/ active or quiescent pulmonary TB. Paradoxical bronchospasm. Pregnancy & lactation.

Click to view Flixotide detailed prescribing information

Use In Pregnancy & Lactation

Click to view Flixotide detailed prescribing information

Adverse Reactions

Mouth & throat candidiasis. Pneumonia (in COPD patients), hoarseness, contusions.

Click to view Flixotide detailed prescribing information

Drug Interactions

Increased plasma conc w/ ritonavir. Potential for increased systemic exposure w/ potent CYP450 3A4 inhibitors eg, ketoconazole.

Click to view Flixotide detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Flixotide detailed prescribing information

Storage

View Flixotide storage conditions for details to ensure optimal shelf-life.

Description

View Flixotide description for details of the chemical structure and excipients (inactive components).

Action

View Flixotide mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03BA05 - fluticasone ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, glucocorticoids.

Regulatory Classification

Presentation/Packing

Form

Flixotide MDI 125 mcg/actuation

Packing/Price

120 actuation x 1's

Form

Flixotide MDI 50 mcg/actuation

Packing/Price

120 actuation x 1's

Flixotide

fluticasone

Manufacturer:

GlaxoSmithKline

Distributor:

GlaxoSmithKline